What's Happening?
Rhode Island Department of Health Director Dr. Jerome “Jerry” Larkin is poised to decide on the proposed sale of three more nursing homes to the AdviniaCare chain: the Respiratory and Rehabilitation Center of Rhode Island in Coventry, Greenville Skilled
Nursing and Rehabilitation, and the Warren Center. The Health Services Council, a state advisory panel, recommended approval on November 10. However, Attorney General Peter Neronha has urged the health department to deny the sale or impose conditions, citing AdviniaCare’s high debt and its use of companies controlled by its owners. Advocates for Better Care in Rhode Island (ABC-RI) also requested conditions, highlighting that all eight existing AdviniaCare nursing homes in Rhode Island have one or two-star ratings from Medicare, and three are candidates for the federal Special Focus Facility program due to serious quality problems. AdviniaCare has been managing these three homes since July 1, 2026, and state inspectors cited Coventry twice and Greenville once for 'immediate jeopardy' between September and November 2026.
Why It's Important?
This decision carries significant implications for the quality of long-term care in Rhode Island and the financial transparency of nursing home operations. If approved, AdviniaCare would own nearly one in five of the state's nursing home beds, raising concerns about potential monopolization and the impact on resident care, especially given the chain's existing low Medicare ratings and 'immediate jeopardy' citations. The Attorney General's intervention and ABC-RI's advocacy underscore a broader concern about private equity and corporate structures in healthcare, where profits may be prioritized over patient well-being. The practice of nursing home owners also owning management companies and other businesses that the homes pay raises questions about potential conflicts of interest and the diversion of funds meant for patient care, particularly when a significant portion of revenue comes from taxpayer-funded Medicaid and Medicare.
What's Next?
Dr. Larkin, as the Director of the Rhode Island Department of Health, will make the final decision on the sale. He has the authority to add conditions to the sale, as proposed by the Attorney General and ABC-RI, which include limits on payments to owner-controlled companies, escrow accounts, independent monitoring, and restrictions on future purchases by AdviniaCare until its existing homes improve. For the longer term, ABC-RI suggests three changes: limiting payments to owner-owned companies, requiring a minimum share of revenue for resident care, and ensuring Medicaid rates adequately cover care costs. This case could set a precedent for how Rhode Island regulates nursing home acquisitions and addresses concerns about quality of care and financial practices in the long-term care sector.
Beyond the Headlines
The controversy surrounding this nursing home sale highlights systemic issues within the U.S. long-term care industry. The pattern of low-rated facilities being acquired by chains with questionable financial structures points to a need for stronger regulatory oversight and enforcement. The argument that 'no one else wants these homes' and that denying a sale could leave residents without care presents a difficult dilemma for regulators, potentially forcing them to choose between approving a problematic sale and risking facility closures. This situation also brings to light the ethical considerations of how taxpayer money, primarily through Medicaid and Medicare, is utilized in a system where profits can be extracted through complex corporate arrangements. The outcome of this decision in Rhode Island could influence policy discussions nationwide regarding the balance between market forces and the imperative to protect vulnerable populations in nursing homes.













